![Michele Washko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michele Washko
Directeur Général chez
Life Sciences Greenhouse of Central Pennsylvania
Profil
Michele Washko is President and CEO of LSG Investments.
She brings to LSG nearly 25 years’ experience in healthcare commercialization, finance and innovation.
She served as V.P., Strategic Services, for the Life Sciences Greenhouse from 2005 until 2015, when she departed for Geisinger Health System’s Institute for Advanced Application.
Ms. Washko went on to found Life Science Innovations, a boutique consulting firm, in 2017 and to serve as COO, then CEO, of Respana Therapeutics, Inc. Ms. Washko holds a Bachelor of Arts degree from Emory University, an MBA from Penn State University, and a certificate in Executive Leadership from M.I.T.
Postes actifs de Michele Washko
| Sociétés | Poste | Début |
|---|---|---|
ProSanos Corp.
 ProSanos Corp. Medical/Nursing ServicesHealth Services Provides health care solutions for the pharmaceutical and biotechnology industries | Directeur/Membre du Conseil | 13/01/2010 |
Life Sciences Greenhouse of Central Pennsylvania
 Life Sciences Greenhouse of Central Pennsylvania Investment ManagersFinance LSGPA invests in companies located in the United States. The firm focuses on drug design, drug delivery systems, biomedical devices, biopharmaceutical manufacturing innovation, drug assay/detection/screening systems and bio nanotechnology. It participates in early-stage capital transactions. | Directeur Général | 01/04/2022 |
Anciens postes connus de Michele Washko
| Sociétés | Poste | Fin |
|---|---|---|
Carbon Nanoprobes, Inc.
 Carbon Nanoprobes, Inc. Medical SpecialtiesHealth Technology Develops and manufactures nanotube-tipped probes for atomic force microscope | Directeur/Membre du Conseil | 20/01/2011 |
Propel Carbon Nanoprobes, Inc. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Michele Washko
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Carbon Nanoprobes, Inc.
Carbon Nanoprobes, Inc. Medical SpecialtiesHealth Technology Develops and manufactures nanotube-tipped probes for atomic force microscope | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcadia University
 Arcadia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Greenhouse of Central Pennsylvania
Life Sciences Greenhouse of Central Pennsylvania Investment ManagersFinance LSGPA invests in companies located in the United States. The firm focuses on drug design, drug delivery systems, biomedical devices, biopharmaceutical manufacturing innovation, drug assay/detection/screening systems and bio nanotechnology. It participates in early-stage capital transactions. | Finance |
ProSanos Corp.
ProSanos Corp. Medical/Nursing ServicesHealth Services Provides health care solutions for the pharmaceutical and biotechnology industries | Health Services |
Propel Carbon Nanoprobes, Inc. |
